Member Info for Vascular

There is no confrontation. Please show me an RNS published after 15th February 21 that mentions the US target of 10,000 store target by a round March / April 22 ? I apologise if I have missed it but I could not find a mention at all.

I would have thought its significant if true, nothing to do with spoiling the board.

Hopeful. I am not trolling the RNSs, it was your post that made me wonder and I checked.

Thanks BB. Why the BODs are confident to discuss this target behind closed doors and not make it a legitimate target by confirming its existence in business update RNSs. It's probably the company's most importance target as far as investors are concerned. Its stuff like this that create uncertainty in investors minds and needs to be corrected.

This explains the massive divide and disparity between investors expectations here on this BB when some investors are told one thing, yet the RNSs that most read do not say anything much at all.

The last mention of 10,000 stores target in US was on 15th February 21 a Progress Update
"Overview

· Pivotal distribution agreements in place

o AATAC rollout has commenced with initial 10,000 stores committed during next phase

o Executed previously announced agreement with prominent UK distributor

o Ox Distribution beta-store programme complete

· Legal and regulatory work underway for new market entry

o UK FSA Novel Foods dossier submitted

o EU compliance work underway

https://www.lse.co.uk/rns/ZOE/progress-update-6f3s2nn85wwwrag.html

HopefulDave. I have just read your post again from 14.12 and noticed this extract. "It doesn't mean the company has stood still in the slightest, it has grown massively. It appears the CEO's saying in the AGM and GM that the distributors are all onboard and 10,000 is still the target itself hasn't moved the SP, as confidence is knocked.".

I think one of the troubles is that this 10,000 target of outlets often spoken about on this BB has never appeared in an RNS.
I just quick checked 24 Feb US Update, 16th April Trading Update, 17th May Update, 1st July Business update, 29th July Business update and so on and all CHILL RNS's from February 21 up until to day - there is no mention of a 10,000 US outlet target at all, and no mention of any target for US outlets being on stream sometime in 2022 !

I am now under the impression that the 10,000 outlet US target has possibly been mentioned verbally at AGMs and GMs, but is just info for those attending, and the company have chosen NOT to identify this as one of its core targets this year in an RNS. WHY. This is exactly what ALL investors want to hear.

Can anyone put me straight if i have missed an RNS mentioning this as a target - and also explain where this number came from ? - lets face it, ALL investors should have the same information, and if it does not appear in an RNS then its a wish, more than a target.

Its stuff like this that makes investors feel uneasy. It would be the easiest thing in the world to just place my faith in the story here...but the 10,000 stores target by April 2021 is integral to the development of CHILL success next year. So why no mention in an RNS? not a de-ramp, but an observation - if i am wrong can easily be corrected by those investors with more in depth knowledge here. GL Vas.

I agree. I think a vaping no nicotine / tobacco product with CBD would be a very good seller in the UK. I use vape and would definitely use it.

If you look at other products on sale they look like old product line of smokies etc . I think this is a vape product that they tried and dropped. I think it is old news. Happy to be wrong - although as far as vaping goes mint would be a better flavour than Vanilla.

Thanks for letting us all know BB and well done.

I think the targets set last year, and earlier this year are still resound among Investors and potential investors and the fact that many of these targets have produced no news or progress and lack of sales / outlets reported has been taken as a red light....and on top of this investors are now expected to trust that the company are suddenly on top of their game with this new nonlinear method of reporting sales ..which I believe will give an even more unpredictable forecast of sales figuress and new outlets over a longer period of time.

If we are wiping the slate clean now and starting a new system of monitoring and reporting growth for the year ahead - I think a sales / outlet update now would be a sensible decision to allay fears from investors going forward and enable investors to actually monitor progress themselves and make their own decisions whether the company is progressing in a manner they are happy with.

Good Twitter feed and I agree.

There are so many variables that dictate the antibody response that any one person will show at anyone time. It involves a perspective change from mass rollout vaccines ( blanket protection for a time) etc to individuals / family's / work groups to one where monitoring their own antibody defence at regular intervals...I think this is where it will all end, that each individual will be responsible to ensure they test their own antibody defence, and if low request a booster or protect themselves until safe.
How else am i going to find out if my body carry's the defence required to reduce the symptoms of Covid, if it is introduce into my body.

So everyone seems to know what is happening here over the next year or so.... So will investors look forward to an update on the last quarter this month?

The big question for this week is will the September Quarterly update materialise this week - there are four more working days in October to go ? Are we linear or non linear now? The last i heard we are non linear which i am told here means that progress can be unpredictable, chunky, random and difficult to assess over a period of time..... I'm confused at the moment, are we still expecting an October RNS detailing the last quarters progress to September 21 or not ?

Beijing Jinwofu Bioengineering Technology Co., Ltd
English /
Jinwofu press releases. This is the latest!

"The Novel Coronavirus (SARS-COV-2) antigen Rapid Test kit has been launched!"

The “COVID-19 Antigen Test Reagent” produced by Jinwofu company has been passed the EU CE certification, and It is also the first test reagent validated by China Food and Drug Control Research Institute.
Jinwofu Novel Coronavirus (SARS-COv-2) antigen Rapit Test Kit has been exported to many countries and has recently signed agreements with related foreign companies to reach cooperation. In order to promote the friendly cooperation of multi-country trade exchanges in the future!
http://www.jwfbio.com/en/

Excellent Questions BB2. Well done for making the effort.

Thanks

published August 21. For Newbys such as myself.

https://aimchaos.files.wordpress.com/2021/08/avacta-group-revised-investment-thesis-summary.pdf

Mologic Ltd Mologic COVID-19 Rapid Test United Kingdom Visual CE-IVD Completed: 1 country Results
updated: 15 Jun 2021
https://www.finddx.org/sarscov2-eval-antigen/

Published on 19th October 21 :)

Posted earlier on ODX site by Marker72. Thanks Marker.
WHO -SARS-CoV-2 Nucleic Acid Tests: progress of the active applications in the emergency use listing assessment pipeline

Mologic on list for both tests.

4th panel - and again in 6th panel , both state desktop assessment completed

https://extranet.who.int/pqweb/sites/default/files/documents/211019_IVDs_SARS-CoV-2_Assessment_EUL.pdf

Is the new list of LFTs expected tomorrow only for travellers? If so, who is in charge of the list for the free tests? Is this list being updated same as the travellers list?

I thought they were doing away with free lateral flow tests !
https://www.standard.co.uk/news/uk/sajid-javid-health-secretary-downing-street-government-b961624.html